BeStock  

Neurocrine Biosciences NBIX

US equityMarket cap rank #1096Drug Manufacturers - Specialty & Generic
$150.57 −$6.02 (-3.84%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $150.57 0.00%
Open$156.27
Prev close$156.59
Day range$150.24 – $158.26
Volume1.59M
Market cap$15.24B
P/E (TTM)22.3
Dividend yield–

Analyst view

ConsensusBuy
Analysts19
Average target$207.35+37.7% vs. price
  • Buy 84%
  • Hold 16%
Low $150.00Now $150.57Avg $207.35High $253.00

Recent rating changes

The last 20 actions on file set price targets from $150.00 to $230.00, averaging $199.61.

DateFirmRatingTarget
13 Nov 2026 Morgan Stanley HOLD $191.00
3 Nov 2026 TD Cowen BUY $220.00
3 Nov 2026 CCORF BUY $220.00
3 Nov 2026 Wells Fargo BUY $200.00
3 Nov 2026 Bernstein BUY $218.00
3 Nov 2026 Piper Sandler BUY $215.00
3 Nov 2026 BofA Securities BUY –
3 Nov 2026 Wedbush BUY $186.00
3 Nov 2026 Morgan Stanley HOLD $185.00
3 Nov 2026 Deutsche Bank HOLD $175.00
3 Nov 2026 Guggenheim BUY $224.00
3 Nov 2026 Oppenheimer BUY $230.00
2 Nov 2026 Cantor Fitzgerald BUY $215.00
2 Nov 2026 Morgan Stanley HOLD $183.00
2 Nov 2026 BMO Capital HOLD $150.00
2 Nov 2026 RBC Capital BUY $190.00
2 Nov 2026 J.P. Morgan BUY –
16 Oct 2026 Needham BUY $204.00
13 Oct 2026 Wells Fargo BUY $200.00
13 Oct 2026 RBC Capital BUY $187.00

Discussion

No comments yet — be the first to weigh in on NBIX.

Sign in to join the discussion.

Scroll to Top